BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha
115 results:

  • 1. Effect of hypoxia‑HIF‑1α‑periostin axis in thyroid cancer.
    Yang Y; Wu J; Zhu H; Shi X; Liu J; Li Y; Wang M
    Oncol Rep; 2024 Apr; 51(4):. PubMed ID: 38391012
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Asiaticoside Down-Regulates HIF-1α to Inhibit Proliferation, Migration, and Angiogenesis in thyroid cancer Cells.
    Zhang Y; Han Y; Dong J; Li F; Sun Y
    Balkan Med J; 2024 Jan; 41(1):23-29. PubMed ID: 38044598
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. HIF-1α regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF-κB signaling pathway.
    Wang D; Liu X; Li M; Ning J
    Mol Carcinog; 2024 Feb; 63(2):238-252. PubMed ID: 37861358
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
    Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
    Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in cancer Cells.
    Zwergel C; Aventaggiato M; Garbo S; Di Bello E; Fassari B; Noce B; Castiello C; Lambona C; Barreca F; Rotili D; Fioravanti R; Schmalz T; Weyand M; Niedermeier A; Tripodi M; Colotti G; Steegborn C; Battistelli C; Tafani M; Valente S; Mai A
    J Med Chem; 2023 Jul; 66(14):9622-9641. PubMed ID: 37439550
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The association of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α protein expression with clinicopathological characteristics in papillary thyroid carcinoma: A meta-analysis.
    Lin X; Su H; Huo J; Zhang F
    Medicine (Baltimore); 2023 Jun; 102(24):e34045. PubMed ID: 37327294
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance.
    Trocchianesi S; Po A; Citarella A; Spinello Z; Rughetti A; Besharat ZM; Autilio TM; Pecce V; Verrienti A; Elisei R; Durante C; Catanzaro G; Ferretti E
    Biomed Pharmacother; 2023 Aug; 164():114995. PubMed ID: 37301138
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype.
    Aprile M; Cataldi S; Perfetto C; Federico A; Ciccodicola A; Costa V
    Br J Cancer; 2023 Aug; 129(2):249-265. PubMed ID: 37198319
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Artemisinin suppresses aerobic glycolysis in thyroid cancer cells by downregulating HIF-1a, which is increased by the XIST/miR-93/HIF-1a pathway.
    Yang F; Zhang J; Zhao Z; Liu Y; Zhao Z; Fu K; Li B; Jin J
    PLoS One; 2023; 18(4):e0284242. PubMed ID: 37036874
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical and pathological features analysis of invasive breast cancer with microcalcification.
    Tian Y; Zhao L; Gui Z; Liu S; Liu C; Yu T; Zhang L
    Cancer Med; 2023 May; 12(10):11351-11362. PubMed ID: 36971046
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. miR-210 Expression Is Strongly Hypoxia-Induced in Anaplastic thyroid cancer Cell Lines and Is Associated with Extracellular Vesicles and Argonaute-2.
    Powell BH; Turchinovich A; Wang Y; Gololobova O; Buschmann D; Zeiger MA; Umbricht CB; Witwer KW
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901936
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression of HIF-1α/PKM2 axis correlates to biological and clinical significance in papillary thyroid carcinoma.
    Hao Z; Wang Y; Li J; Liu W; Zhao W; Wang J
    Medicine (Baltimore); 2023 Mar; 102(10):e33232. PubMed ID: 36897686
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. LINC00365 functions as a tumor suppressor by inhibiting HIF-1α-mediated glucose metabolism reprogramming in breast cancer.
    Liu B; Qu X; Wang J; Xu L; Zhang L; Xu B; Su J; Bian X
    Exp Cell Res; 2023 Apr; 425(1):113514. PubMed ID: 36804531
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CRISPR screening reveals gleason score and castration resistance related oncodriver ring finger protein 19 A (RNF19A) in prostate cancer.
    Zhang N; Huang D; Ruan X; Ng AT; Tsu JH; Jiang G; Huang J; Zhan Y; Na R
    Drug Resist Updat; 2023 Mar; 67():100912. PubMed ID: 36623445
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. HIF-1α/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary thyroid cancer Progression.
    Song H; Qiu Z; Wang Y; Xi C; Zhang G; Sun Z; Luo Q; Shen C
    Int J Biol Sci; 2023; 19(1):225-241. PubMed ID: 36594102
    [No Abstract]    [Full Text] [Related]  

  • 16. Different Expression of thyroid-Specific Proteins in thyroid cancer Cells between 2-Dimensional (2D) and 3-Dimensional (3D) Culture Environment.
    Oh JM; Gangadaran P; Rajendran RL; Hong CM; Lee J; Ahn BC
    Cells; 2022 Nov; 11(22):. PubMed ID: 36428988
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. HIF-1α and Caspase-3 expression in aggressive papillary thyroid carcinoma.
    Zhang L; Shi B; Hu M; Qian L
    World J Surg Oncol; 2022 Nov; 20(1):353. PubMed ID: 36329448
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting Tumor Hypoxia Inhibits Aggressive Phenotype of Dedifferentiated thyroid cancer.
    Ma B; Wen S; Luo Y; Zhang T; Yang Y; Shen C; Zhang Y; Ji Q; Qu N; Wang Y
    J Clin Endocrinol Metab; 2023 Jan; 108(2):368-384. PubMed ID: 36190930
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Isoproterenol-induced Upregulation of HPSE Accelerates Triple-negative Breast cancer Cell Proliferation and Migration through Enhancing the Transcriptional Activity of HIF-1α.
    Qiu J; Shen Z; Jiang G; Ni Q
    Anticancer Agents Med Chem; 2023; 23(4):470-477. PubMed ID: 35980070
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Human umbilical cord mesenchymal stem cell promotes angiogenesis via integrin β1/ERK1/2/HIF-1α/VEGF-A signaling pathway for off-the-shelf breast tissue engineering.
    Wu M; Chen L; Qi Y; Ci H; Mou S; Yang J; Yuan Q; Yao W; Wang Z; Sun J
    Stem Cell Res Ther; 2022 Mar; 13(1):99. PubMed ID: 35255978
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.